Employed in standard Chinese, Ayurvedic, and Thai drugs. Conolidine could signify the beginning of a new era of chronic pain management. It is currently being investigated for its effects on the atypical chemokine receptor (ACK3). Inside a rat product, it had been uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3